Infection with toxin a-negative, toxin b-negative, binary toxin-positive clostridium difficile in a young patient with ulcerative colitis

Journal of Clinical Microbiology

Volumn 53, Issue 11, 2015, Pages 3702-3704

  Androga, Grace O ^a   Hart, Julie ^b   Foster, Niki F ^a,b   Charles, Adrian ^c   Forbes, David ^a,c   Riley, Thomas V ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b PATHWEST LABORATORY MEDICINE   (Australia)

^c PRINCESS MARGARET HOSPITAL FOR CHILDREN   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BACTERIAL TOXIN; CALGRANULIN; CLINDAMYCIN; FIDAXOMICIN; HEMOGLOBIN; INFLIXIMAB; MESALAZINE; METRONIDAZOLE; MOXIFLOXACIN; MUCIN; NORFLOXACIN; PREDNISOLONE; RIFAXIMIN; VANCOMYCIN; ACTIN-SPECIFIC ADP-RIBOSYLTRANSFERASE, CLOSTRIDIUM; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; ENTEROTOXIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; TCDA PROTEIN, CLOSTRIDIUM DIFFICILE; TOXB PROTEIN, CLOSTRIDIUM DIFFICILE;

ABDOMINAL PAIN; ADOLESCENT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL GROWTH; BLOOD ANALYSIS; BLOODY DIARRHEA; CASE REPORT; CDTA GENE; CDTAB GENE; CLOSTRIDIUM DIFFICILE INFECTION; COLON DISEASE; COLON RESECTION; CRYPT ABSCESS; DIARRHEA; DISEASE DURATION; DISEASE SEVERITY; DRUG TREATMENT FAILURE; ENTERITIS; ERYTHROCYTE SEDIMENTATION RATE; FECES ANALYSIS; FECES CULTURE; FEVER; GENE IDENTIFICATION; GIANT CELL; HEMOGLOBIN BLOOD LEVEL; HISTOPATHOLOGY; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; HUMAN TISSUE; INFECTIOUS DIARRHEA; INFLAMMATORY BOWEL DISEASE; INFLAMMATORY INFILTRATE; INTESTINE ENDOSCOPY; LETHARGY; MALE; PEPTOCLOSTRIDIUM DIFFICILE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEPLETION; RECURRENT DISEASE; TCDB GENE; THROMBOCYTE COUNT; THROMBOCYTOSIS; TREATMENT WITHDRAWAL; ULCERATIVE COLITIS; WEIGHT REDUCTION; AUSTRALIA; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FECES; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PATHOGENICITY;

ADOLESCENT; ADP RIBOSE TRANSFERASES; ANTI-BACTERIAL AGENTS; AUSTRALIA; BACTERIAL PROTEINS; BACTERIAL TOXINS; CLOSTRIDIUM DIFFICILE; COLITIS, ULCERATIVE; ENTEROCOLITIS, PSEUDOMEMBRANOUS; ENTEROTOXINS; FECES; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; RECURRENCE;

EID: 84945241939     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01810-15     Document Type: Article

References (13)

1. Knight DR, Thean S, Putsathit P, Fenwick S, Riley TV. 2013. Cross-sectional study reveals high prevalence of Clostridium difficile non-PCR ribotype 078 strains in Australian veal calves at slaughter. Appl Environ Microbiol 79:2630-2635. http://dx.doi.org/10.1128/AEM.03951-12.
2. Knight DR, Giglio S, Huntington PG, Korman TM, Kotsanas D, Moore CV, Paterson DL, Prendergast L, Huber CA, Robson J, Waring L, Wehrhahn MC, Weldhagen GF, Wilson RM, Riley TV. 28 July 2015. Surveillance for antimicrobial resistance in Australian isolates of Clostrid-ium difficile, 2013-14. J Antimicrob Chemother http://dx.doi.org/10.1093/jac/dkv220.
3. LaMont JT, Trnka YM. 1980. Therapeutic implications of Clostridium difficile toxin during relapse of chronic inflammatory bowel disease. Lancet i:381-383.
4. Nitzan O, Elias M, Chazan B, Raz R, Saliba W. 2013. Clostridium difficile and inflammatory bowel disease: role in pathogenesis and implications in treatment. World J Gastroenterol 19:7577-7585. http://dx.doi.org/10.3748/wjg.v19.i43.7577.
5. Wang T, Matukas L, Streutker CJ. 2013. Histologic findings and clinical characteristics in acutely symptomatic ulcerative colitis patients with superimposed Clostridium difficile infection. Am J Clin Pathol 140:831-837. http://dx.doi.org/10.1309/AJCP2LBRTTJBF3KD.
6. Cojocariu C, Stanciu C, Stoica O, Singeap AM, Sfarti C, Girleanu I, Trifan A. 2014. Clostridium difficile infection and inflammatory bowel disease. Turk J Gastroenterol 25:603-610. http://dx.doi.org/10.5152/tjg.2014.14054.
7. Sandberg KC, Davis MM, Gebremariam A, Adler J. 2015. Disproportionate rise in Clostridium difficile-associated hospitalizations among US youth with inflammatory bowel disease, 1997-2011. J Pediatr Gastroenterol Nutr 60: 486-492. http://dx.doi.org/10.1097/MPG.0000000000000636.
8. Popoff MR, Rubin EJ, Gill DM, Boquet P. 1988. Actin-specific ADP-ribosyltransferase produced by aClostridium difficile strain. Infect Immun 56:2299-2306.
9. Eckert C, Emirian A, Le Monnier A, De Montclos H, Goret J, Berger P, Petit A, De Chevigny A, Jean-Pierre H, Nebbad B, Camiade S, Meck-enstock R, Lalande V, Marchandin H, Babut F. 2015. Prevalence and pathogenecity of binary toxin-positive Clostridium difficile strains that do not produce toxins A and B. New Microbes New Infect 3:12-17. http://dx.doi.org/10.1016/j.nmni.2014.10.003.
10. Walker AS, Eyre DW, Wyllie DH, Dingle KE, Griffiths D, Shine B, Oakley S, O'Connor L, Finney J, Vaughan A, Crook DW, Wilcox MH, Peto TE. 2013. Relationship between bacterial strain type, host biomark-ers, and mortality in Clostridium difficile infection. Clin Infect Dis 56: 1589-1600. http://dx.doi.org/10.1093/cid/cit127.
11. Knight DR, Squire MM, Riley TV. 2015. Nationwide surveillance study of Clostridium difficile in Australian neonatal pigs shows high prevalence and heterogeneity ofPCR ribotypes. Appl Environ Microbiol 81:119-123. http://dx.doi.org/10.1128/AEM.03032-14.
12. Androga GO, McGovern AM, Elliott B, Chang BJ, Perkins TT, Foster NF, Riley TV. 2015. Evaluation of the Cepheid Xpert C. difficile/Epi and Meridian Bioscience Illumigene C. difficileassays for detectingClostridium difficile ribotype 033 strains. J Clin Microbiol 53:973-975. http://dx.doi.org/10.1128/JCM.03297-14.
13. Bauer MP, Notermans DW, van Benthem BH, Brazier JS, Wilcox MH, Rupnik M, Monnet DL, van Dissel JT, Kuijper EJ. 2011. Clostridium difficile infection in Europe: a hospital-based survey. Lancet 377:63-73. http://dx.doi.org/10.1016/S0140-6736(10)61266-4.